Executive Assistant to CEO

P&G to acquire supplement company Thorne for US$3.8B to boost health portfolio. Key takeaways. * P&G will purchase Thorne from L Catterton to expand its Health Care portfolio for US$3.8 billion. * The company expects the acquired brand and products to enable its portfolio to meet demand for preventive wellness and self-care. * The agreement is the latest in a range of business deals where large consumer goods companies purchase science-backed nutrition and supplements brands. P&G has entered into a definitive agreement to acquire Thorne, which will join its Health Care portfolio. With the acquisition, P&G expects to better meet growing consumer demand for preventive and personalized health. Investment firm L Catterton has reported that it is selling Thorne for US$3.8 billion. P&G's CEO, Shailesh Jejurikar, confirmed this purchase price in an interview with CNBC yesterday. Thorne provides health and wellness solutions to consumers, athletes, and health care professionals. Paul Gama, CEO of P&G Health Care, says the acquisition is an important step for the business. "Consumer interest in self-care, prevention, wellness, and personalized health continues to grow, and Thorne strengthens our position in premium wellness with a trusted, science-backed brand that complements our existing portfolio." The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions and regulatory approvals. Personalized health. Thorne says that the acquisition will help it further build its personalized health brand by helping consumers live healthier with efficacious solutions. "For more than 40 years, Thorne has earned the trust of health care practitioners, consumers, and partners by putting science, quality, and the people we serve at the center of every decision," says Colin Watts, CEO of Thorne. "P&G is the right partner to help us expand our impact while staying true to the values and standards that have always defined Thorne." Thorne's portfolio includes supplements and technology, such as its AI-powered wellness advisor Taia. Gama of P&G adds: "We see an opportunity to bring Thorne's science-backed wellness solutions to more consumers while continuing to build on the quality, credibility, and innovation that have made the brand successful." Wellness mergers & acquisitions. P&G's acquisition of Thorne is the latest in a range of business deals in the nutrition and health space. H&H Group's CFO previously told Nutrition Insight that there is a strong appetite for acquisitions and investments into the health and wellness market, specifically in nutrition. "Established businesses are recognizing that acquiring health and wellness brands, with loyal consumer bases and proven efficacy, is the fast route to diversification and growth," said Jason Wang. Recent acquisitions include Lactalis' purchase of the UK active nutrition brand Protein Works, while Unilever made a deal to acquire the US-based green supplement company Grüns. Additionally, functional ingredients supplier SuanNutra signed an agreement to buy a portfolio of specialty natural ingredients from IFF, and Ingredion purchased the Benicaros prebiotic from NutriLeads as a strategic addition to its Healthful Solutions portfolio.

How Gruns 20x'd ROI with FrontrowMD. Gruns saw a 15% CVR lift when proving to shoppers that over 1,000 clinicians were sharing their flagship Greens Gummy on FrontrowMD (without compensation), including raving reviews from clinicians about why they loved this solution for their patients. Irfan Alam Chief Executive Officer May 1, 2026 "Scaling clinician support through FrontrowMD has been effortless and our shoppers resonate strongly with this kind of expert validation - the impact to growth has been tremendous. Shoppers face so much confusion in an exploding Wellness category and FrontrowMD has been one of the best ways to cut through that noise." - Connor Dault, Chief Marketing Officer. Background. Gruns is one of the fastest growing consumer brands in history, certainly in the Wellness category, where they found the perfect Gummy form factor to accompany an expansive formulation of nutrient-dense ingredients. However, there's tons of noise in the "Greens" space with many similar brands trying to replicate Gruns's success, or market similar products with different form factors. The problem. Shoppers naturally question - is the gummy form factor as effective? Do I really need to pay for a product that has all 60+ ingredients? Is this really better than the other products I'm seeing on TikTok? That's when Gruns decided to partner with FrontrowMD - to leverage medical experts and combat shopper skepticism. Getting started with FrontrowMD. Gruns's first question was - how quickly can FrontrowMD get more than a thousand clinicians to support its product? Luckily, by the time Gruns met with its team, FrontrowMD already had thousands of clinicians in its network, many of whom FrontrowMD regularly revisit in person to chat with them about new products, samples, and how to share the best of what's on the market with their patients. Its Medical Advisory board studied their product and its internal Medical Researchers began drafting research summaries to help educate its clinicians, who know that products have to go through screening, scoring, approval/rejection, research summarization, etc., all before clinicians even see it as an option to share with patients. Within months, hundreds of clinicians were sharing Gruns on FrontrowMD, without compensation. Implementing 'badges' on Gruns's PDP. Implementation happened in a matter of days - Gruns's team met with FrontrowMD's Solution Engineers who explained its 'Code Snippets' that can be copy and pasted into Gruns's back-end without any complicated API integration. Solution Engineers walked through this during a live screenshare, and Gruns's team was able to implement, QA, test for impact to site speed, etc., and go live in just a couple days. Results. Gruns ran a statistically significant AB test over the coming month with tens of thousands of shoppers, where 50% of web traffic was directed to a version of the landing page with FrontrowMD offerings, and the rest of the traffic was randomly directed to a similar page that did not have any FrontrowMD offerings. The results were staggering - a clear 15% lift in CVR, driving a 20x ROI on the cost of the FrontrowMD platform. That was a massive win for Gruns, especially considering the cost (and time/energy) they would have incurred if they built their own pharma-like sales force to build relationships with 1,000+ clinicians from scratch, and have no easy way to digitally track and independently verify this kind of data. Bottom line. As Chad, the CEO, said it best on Linkedin, when listing the partners that played an important role in Gruns's rocket-ship growth, he listed FrontrowMD and its "medical badging" as being critical - to be a category-defininging leader, Chad knows the importance of having the overwhelming support of the scientific community. Get the Latest Health and Wellness Insights